Epigenetic Health Benefits of Budesonide

Clinical trial NCT04342039 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04342039
Sponsor: University of British Columbia
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Epigenetic Effects of Intranasal Steroids Environmental Exposure

Start date: 2021-01-07
Primary completion: 2025-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.